These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1221 related articles for article (PubMed ID: 28417346)
21. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843 [TBL] [Abstract][Full Text] [Related]
22. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Rajapakse S; Rodrigo C; Fernando SD Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416 [TBL] [Abstract][Full Text] [Related]
23. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries. Recht J; Ashley EA; White NJ PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516 [TBL] [Abstract][Full Text] [Related]
24. Primaquine treatment and relapse in Plasmodium vivax malaria. Rishikesh K; Saravu K Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309 [TBL] [Abstract][Full Text] [Related]
25. Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review. Drysdale M; Tan L; Martin A; Fuhrer IB; Duparc S; Sharma H Infect Dis Ther; 2023 Jan; 12(1):33-51. PubMed ID: 36378465 [TBL] [Abstract][Full Text] [Related]
26. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report. He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061 [TBL] [Abstract][Full Text] [Related]
27. Implementation of G6PD testing and primaquine for Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064 [TBL] [Abstract][Full Text] [Related]
28. Towards one standard treatment for uncomplicated Plasmodium falciparum and Plasmodium vivax malaria: Perspectives from and for the Peruvian Amazon. Fernandez-Miñope C; Delgado-Ratto C; Contreras-Mancilla J; Ferrucci HR; Llanos-Cuentas A; Gamboa D; Van Geertruyden JP Int J Infect Dis; 2021 Apr; 105():293-297. PubMed ID: 33596478 [TBL] [Abstract][Full Text] [Related]
29. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial. Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363 [TBL] [Abstract][Full Text] [Related]
30. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Galappaththy GN; Tharyan P; Kirubakaran R Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057 [TBL] [Abstract][Full Text] [Related]
31. Plasmodium vivax in the Era of the Shrinking P. falciparum Map. Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682 [TBL] [Abstract][Full Text] [Related]
32. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199 [TBL] [Abstract][Full Text] [Related]
33. Growing evidence of Plasmodium vivax across malaria-endemic Africa. Twohig KA; Pfeffer DA; Baird JK; Price RN; Zimmerman PA; Hay SI; Gething PW; Battle KE; Howes RE PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007140. PubMed ID: 30703083 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030. Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940 [TBL] [Abstract][Full Text] [Related]
35. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose? Chen IT; Gosling RD Expert Rev Clin Pharmacol; 2014 Nov; 7(6):681-6. PubMed ID: 25118908 [TBL] [Abstract][Full Text] [Related]
36. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis. Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417 [TBL] [Abstract][Full Text] [Related]
37. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens. Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391 [TBL] [Abstract][Full Text] [Related]
38. The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on haemoglobin levels in Ethiopia: a longitudinal cohort study. Habtamu K; Getachew H; Abossie A; Demissew A; Tsegaye A; Degefa T; Wang X; Lee MC; Zhou G; Kibret S; King CL; Kazura JW; Petros B; Yewhalaw D; Yan G Malar J; 2024 Jul; 23(1):208. PubMed ID: 38997771 [TBL] [Abstract][Full Text] [Related]